Mainz Biomed N.V (NASDAQ:MYNZ) traded at $1.98 at close of the session on Tuesday, July 15 and made an upward move of 7.03% on its previous day’s price.
Looking at the stock we see that its previous close was $1.85 and the beta (5Y monthly) reads 0.305 with the day’s price range being $1.6201 – $2.12. In terms of its 52-week price range, MYNZ has a high of $19.00 and a low of $1.34. The company’s stock has lost about -0.50% over that past 30 days.
Mainz Biomed N.V has a market cap of $7.56 million and is expected to release its quarterly earnings report on 2025-Mar-31.
On the other hand, looking at the outlook for the MYNZ stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Looking further, we note the current price level is 26.36% off its SMA20 and 1.13% from its 50-day simple moving average. The RSI (14) is pointing at 59.30 while the volatility over the past week is 18.41% and jumps to 10.28% over the past one month.
Coming back to Mainz Biomed N.V (NASDAQ:MYNZ), we note that the average 3-month trading volume was 181.88K, while that of the preceding 10-day period stands at 0.15 million. Current shares outstanding are 3.81 million.
The insiders hold 3.35% of the company’s shares while institutions hold 6.13%. The data shows that short shares as of 2025-06-13, stood at 7818.0 at a short ratio of 0.09. This represents a 21.00 short interest in shares outstanding on 2025-06-13. Shares short fall in June from the previous month at 96184.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -89.32% down in year-to-date price movement.
